Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.
Avenue Therapeutics has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2023.
Avenue Therapeutics is headquartered in New York, United States.
Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.
Avenue Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avenue Therapeutics — Funding & Investors." VCBacked, October 31, 2023, https://www.vcbacked.co/company/avenue-therapeutics. Accessed August 31, 2026.
VCBacked. (2023). Avenue Therapeutics — Funding & Investors. Retrieved August 31, 2026, from https://www.vcbacked.co/company/avenue-therapeutics
{{cite web |title=Avenue Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avenue-therapeutics |website=VCBacked |access-date=August 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated